Diabetes drugs are badly needed, but rarely make it to market
(By Ed Silverman for ST A T) Diabetes 1 may be a widespread disease for which millions of people need
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Ed Silverman for ST A T) Diabetes 1 may be a widespread disease for which millions of people need
Read moreOn Friday, Blue Cross Blue Shield of Nebraska announced they are pulling out of Obamacare marketplace in the state citing
Read moreWhile health care has not been central to the 2016 Presidential campaign, the election’s outcome will be a major determining
Read more(By Damian Garde for ST A T) T he Food and Drug Administration on Friday approved a lower-cost version of
Read more(By Sharon Begley for ST A T) N EW YORK — There’s been a lot of excitement about immunotherapy 1
Read more(By Jon Hamilton for NPR) There’s growing evidence that a physical injury to the brain can make people susceptible to
Read more(by Arun Rath for NPR) When Harry Selker was working as a cardiologist in the 1970s, clot-busting drugs were showing
Read more(By Pauline Bartolone for California Healthline) At first blush, the tobacco tax measure on California’s November ballot looks pretty straightforward.
Read more(By Zhai Yun Tan for Kaiser Health News) Many people take for granted the addition of fluoride into public drinking
Read more(By Melissa Quinn for The Daily Signal) In the wake of news that pharmaceutical company Mylan quadrupled the price of
Read more